FDA Peptide Reclassification 2026 Amanecia Health FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what GHK Cu Peptide (50mg) Advanced Skin Rejuvenation & Healing Support FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica